Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

July 2017

ANTHEM LAUNCHES PROGRAM TO MANAGE GENETIC TESTS

CEO SUMMARY:Ā Pre-authorization of genetic tests is coming to physicians serving patients insured by Anthem, Inc. Its specialty benefits management company, AIM Specialty Health, will manage the program. AIM will work with InformedDNA, a company that specializes in genetic testing clinical decision support and genetic counseling for health insurers. Anthem has about 40 million members in […]

To access this post, you must purchase The Dark Report.

ANTHEM LAUNCHES PROGRAM TO MANAGE GENETIC TESTS Read More Ā»

Labs Beware! More Patients Have Higher Deductibles

ONE TREND THAT PUTS FINANCIAL PRESSURE on both clinical laboratories and pathology groups is the growing number of patients who have higher deductibles. This means labs must work harder and smarter to collect all the money that is due them from the patients they serve. How advanced is this trend? Last fall, the Kaiser Family

To access this post, you must purchase The Dark Report.

Labs Beware! More Patients Have Higher Deductibles Read More Ā»

Konica Minolta to Pay Up to $1 Billion for Ambry

CEO SUMMARY: Itā€™s the second time in six years that a Japanese corporation paid a high price for a genetic testing company in the United States. Konica Minolta will purchase Ambry Genetics for $800 million at closing and $200 million upon hitting certain financial metrics. In 2011, Miraca Holdings acquired Caris Life Sciences for $725

To access this post, you must purchase The Dark Report.

Konica Minolta to Pay Up to $1 Billion for Ambry Read More Ā»

USCā€™s Clive Taylor, MD, Talks Digital Path, WSI

CEO SUMMARY: The FDAā€™s clearance of the first digital pathology system for use in primary diagnosis will be a disruptive force for pathologists in the coming years. At the University of Southern California Keck School of Medicine, pathologist Clive Taylor, MD, predicts that the benefits of whole slide imaging and digital pathology will enable pathologists

To access this post, you must purchase The Dark Report.

USCā€™s Clive Taylor, MD, Talks Digital Path, WSI Read More Ā»

Hospital Lab Data Essential For CMS Market Price Study

CEO SUMMARY: In five months, Medicare officials will implement a new Part B clinical laboratory fee schedule based on private payer lab price data submitted by certain medical laboratories required to report that data. At this yearā€™s Executive War College, the CEO of XIFIN, Inc., reported on her companyā€™s analysis of the payer price data

To access this post, you must purchase The Dark Report.

Hospital Lab Data Essential For CMS Market Price Study Read More Ā»

Details Emerge About End of 31-Year Lab JV

CEO SUMMARY: Quest Diagnostics is no longer an equity partner in the CompuNet Clinical Laboratory joint venture, which has operated successfully since its founding in 1986. Typical of other lab JVs and inpatient lab management agreements that the hospital or health system partners do not renew, none of the owners of CompuNet will comment on

To access this post, you must purchase The Dark Report.

Details Emerge About End of 31-Year Lab JV Read More Ā»

July 17, 2017 Intelligence: Late Breaking Lab News

Hereā€™s an update onĀ Theranos, the troubled lab company that is struggling to stay alive. Once again, reporter John Carreyrou of The Wall Street Journal scooped his peers by reporting that Theranos has listed its corporate offices for lease. For lab companies shopping for office space in Palo Alto, Calif., Theranos has listed its 116,172 square

To access this post, you must purchase The Dark Report.

July 17, 2017 Intelligence: Late Breaking Lab News Read More Ā»

Ambry Genetics $800M Sale to Konica Minolta Is a Big Deal for Lab Industry

This is an excerpt from a 2,026-word article in the July 17, 2017 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: Itā€™s the second time in six years that a Japanese

To access this post, you must purchase The Dark Report.

Ambry Genetics $800M Sale to Konica Minolta Is a Big Deal for Lab Industry Read More Ā»

;